Protalix BioTherapeutics (PLX) Other Working Capital Changes (2010 - 2024)
Protalix BioTherapeutics' quarterly Other Working Capital Changes came in at $252062.0 in Q4 2024, down 84.78% quarter-over-quarter from $1.7 million in Q2 2024.
Protalix BioTherapeutics has reported Other Working Capital Changes for 15 years, with the latest figure at $252062.0 in Q4 2024.
- For the quarter ending Q4 2024, Other Working Capital Changes changed N/A year-over-year to $252062.0; the trailing twelve-month figure through Dec 2024 stood at $252062.0 (up 101.91% YoY), and the FY2024 full-year result was $252062.0, up 101.91% from the prior year.
- Other Working Capital Changes for Q4 2024 stood at $252062.0, down from $1.7 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $12.3 million in Q2 2021, with the low at -$25.7 million in Q4 2020.
- Average Other Working Capital Changes over 5 years is -$2.1 million, with a median of -$192500.0 recorded in 2020.
- Year-over-year, Other Working Capital Changes sank 14850.0% in 2020 and surged 14394.19% in 2021.
- Tracing PLX's Other Working Capital Changes over 5 years: stood at -$25.7 million in 2020, then jumped by 45.63% to -$14.0 million in 2021, then soared by 88.46% to -$1.6 million in 2022, then plunged by 630.03% to -$11.8 million in 2023, then jumped by 102.14% to $252062.0 in 2024.
- The last three Other Working Capital Changes figures came in at $252062.0 (Q4 2024), $1.7 million (Q2 2024), and $11.0 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 252,062.00 |
| Dec 31, 2024 | 252,062.00 |
| Jun 30, 2024 | 1.66 Mn |
| Jun 30, 2024 | 1.66 Mn |
| Mar 31, 2024 | 11.04 Mn |
| Mar 31, 2024 | 11.04 Mn |
| Jun 30, 2023 | -11.79 Mn |
| Jun 30, 2023 | -11.79 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Mar 31, 2023 | -1.39 Mn |
| Dec 31, 2022 | -1.62 Mn |
| Dec 31, 2022 | -1.62 Mn |
| Sep 30, 2022 | -2.90 Mn |
| Sep 30, 2022 | -2.90 Mn |
| Mar 31, 2022 | -2.64 Mn |
| Mar 31, 2022 | -2.64 Mn |
| Dec 31, 2021 | -14.00 Mn |
| Dec 31, 2021 | -14.00 Mn |
| Sep 30, 2021 | 1.68 Mn |
| Sep 30, 2021 | 1.68 Mn |
| Jun 30, 2021 | 12.29 Mn |
| Jun 30, 2021 | 12.29 Mn |
| Mar 31, 2021 | -25,000.00 |
| Mar 31, 2021 | -25,000.00 |
| Dec 31, 2020 | -25.74 Mn |
| Dec 31, 2020 | -25.74 Mn |
| Sep 30, 2020 | -78,000.00 |
| Sep 30, 2020 | -78,000.00 |
| Jun 30, 2020 | -86,000.00 |
| Jun 30, 2020 | -86,000.00 |
| Mar 31, 2020 | -299,000.00 |
| Mar 31, 2020 | -299,000.00 |
| Dec 31, 2019 | -562,000.00 |
| Dec 31, 2019 | -562,000.00 |
| Sep 30, 2019 | 24,000.00 |
| Sep 30, 2019 | 24,000.00 |
| Jun 30, 2019 | 58,000.00 |
| Jun 30, 2019 | 58,000.00 |
| Mar 31, 2019 | -2,000.00 |
| Mar 31, 2019 | -2,000.00 |
| Dec 31, 2018 | -18.02 Mn |
| Dec 31, 2018 | -18.02 Mn |
| Sep 30, 2018 | 18.22 Mn |
| Sep 30, 2018 | 18.22 Mn |
| Jun 30, 2018 | -80,000.00 |
| Jun 30, 2018 | -80,000.00 |
| Mar 31, 2018 | 121,000.00 |
| Mar 31, 2018 | 121,000.00 |
| Dec 31, 2017 | 25.02 Mn |
| Dec 31, 2017 | 25.02 Mn |
| Sep 30, 2017 | -1.93 Mn |
| Sep 30, 2017 | -1.93 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Mar 31, 2017 | 1.09 Mn |
| Dec 31, 2016 | -120,000.00 |
| Dec 31, 2016 | -120,000.00 |
| Sep 30, 2016 | -164,000.00 |
| Sep 30, 2016 | -164,000.00 |
| Jun 30, 2016 | -127,000.00 |
| Jun 30, 2016 | -127,000.00 |
| Dec 31, 2015 | -107,000.00 |
| Dec 31, 2015 | -107,000.00 |
| Sep 30, 2015 | 348,000.00 |
| Sep 30, 2015 | 348,000.00 |
| Jun 30, 2015 | -60,000.00 |
| Jun 30, 2015 | -60,000.00 |
| Mar 31, 2015 | 181,000.00 |
| Mar 31, 2015 | 181,000.00 |
| Mar 31, 2014 | -2.90 Mn |
| Mar 31, 2014 | -2.90 Mn |
| Dec 31, 2013 | -1.77 Mn |
| Dec 31, 2013 | -1.77 Mn |
| Sep 30, 2013 | -1.19 Mn |
| Sep 30, 2013 | -1.19 Mn |
| Jun 30, 2013 | -1.47 Mn |
| Jun 30, 2013 | -1.47 Mn |
| Mar 31, 2013 | -2.74 Mn |
| Mar 31, 2013 | -2.74 Mn |
| Dec 31, 2012 | 6.26 Mn |
| Dec 31, 2012 | 6.26 Mn |
| Sep 30, 2012 | -1.44 Mn |
| Sep 30, 2012 | -1.44 Mn |
| Jun 30, 2012 | -1.14 Mn |
| Jun 30, 2012 | -1.14 Mn |
| Mar 31, 2012 | -2.41 Mn |
| Mar 31, 2012 | -2.41 Mn |
| Dec 31, 2011 | -2.01 Mn |
| Dec 31, 2011 | -2.01 Mn |
| Sep 30, 2011 | -1.14 Mn |
| Sep 30, 2011 | -1.14 Mn |
| Jun 30, 2011 | 1.29 Mn |
| Jun 30, 2011 | 1.29 Mn |
| Mar 31, 2011 | -1.14 Mn |
| Mar 31, 2011 | -1.14 Mn |
| Dec 31, 2010 | -1.14 Mn |
| Dec 31, 2010 | -1.14 Mn |
| Sep 30, 2010 | -1.14 Mn |
| Sep 30, 2010 | -1.14 Mn |